The food ingredients firm targets $130M in annual synergies by 2030 from its Tate & Lyle acquisition.
Ingredion raised its 2026 adjusted earnings per share guidance to a range of $10.30 to $10.90, citing progress on its Tate & Lyle integration. The company expects $130M in run-rate synergies by 2030 from the deal.
Second-quarter net sales rose 1% year-over-year to $1.85 billion, matching expectations. Growth was driven by strength in Texture & Healthful Solutions, management said during the earnings call.
The updated EPS outlook reflects confidence in cost efficiencies and revenue growth from the acquisition. No immediate market reaction was disclosed.